Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Time to first relapse as an endpoint in multiple sclerosis clinical trials.
[Characteristics of arterial tension in multiple sclerosis (biometric-statistical data)].
Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.
The effect of group psycho-education program on the burden of family caregivers with multiple sclerosis patients in Isfahan in 2013-2014.
Improving Multiple Sclerosis Plaque Detection Using a Semiautomated Assistive Approach.
Smoking increases the risk of multiple sclerosis in Queensland, Australia.
Antibodies to MOG in NMO: A seasoned veteran finds a new role.
Free radicals: properties, sources, targets, and their implication in various diseases.
Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study.
Chemokine receptor expression of T cells in the cerebrospinal fluid of relapsing multiple sclerosis.
Neuroprotection and repair in multiple sclerosis.
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?
Step-rate thresholds for physical activity intensity in persons with multiple sclerosis.
Italian validation of the 12-item multiple sclerosis walking scale.
A Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple Sclerosis.
Compare before deciding. Treatment of relapsing-remitting multiple sclerosis.
Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.
Fatigue is associated with poor sleep in people with multiple sclerosis and cognitive impairment.
The CD27 and CD70 Costimulatory Pathway Inhibits Effector Function of T Helper 17 Cells and Attenuates Associated Autoimmunity.
Uveitis- a rare disease often associated with systemic diseases and infections- a systematic review of 2619 patients.
Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.
Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability.
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination.
Cognitive impairment in MS: Impact of white matter integrity, gray matter volume, and lesions.
Efficacy of A Telephone-Delivered Self-Management Intervention For Persons With Multiple Sclerosis: a Randomized Controlled Trial With a One-Year Follow-Up.

Pages